The University of Ottawa Department of Cellular and Molecular Medicine (CMM), is a large, dynamic and interdisciplinary department consisting of 49 faculty researchers and teaching staff, as well approximately 63 cross-appointed and adjunct members. CMM was formed from the combined resources of three former departments of the University of Ottawa: Physiology, Pharmacology and Anatomy & Neurobiology.
CMM boasts a large number of highly active research laboratories investigating important questions related to human health and disease. Some areas of interest include neuromuscular and neurodegenerative diseases, stem cell biology and its application to regenerative medicine, the basis for and treatment of various cancers, causes and cures for kidney disease, understanding the contribution of cellular signaling pathways to disease states, and the causes underlying congenital disorders such as neural tube defects.
CMM is part of the Ottawa Health Sciences Centre, a medical complex which also includes the Ottawa Hospital (General Campus), the Children͛s Hospital of Eastern Ontario (CHEO), the Ottawa Hospital Research Institute (OHRI) and the Children͛s Hospital of Eastern Ontario Research Institute (CHEORI). In addition, through its cross-appointed and adjunct members, the Department has research affiliations with OHRI, the University of Ottawa Heart Institute at the Ottawa Hospital (Civic Campus), the Royal Ottawa Hospital, the Canadian Red Cross, Health Canada and the National Research Council. These relationships greatly facilitate interactions of CMM members with clinicians and researchers involved in diverse aspects of human medicine.
Posted on Friday, April 1, 2022
Gold and Silver for our CMM Trainees at the 2021 CSHRF
Posted on Tuesday, March 15, 2022
The research team developed a new technology combining nanogold and peptides that can restore both heart function and electrical conductivity
Posted on Thursday, February 17, 2022
With innovation and scientific rigour in plentiful supply at the uOttawa Faculty of Medicine, a new grant program aims to provide our top-flight researchers with the assistance needed to bring the benefits of their most promising breakthroughs to the wider world.